More than 100 dead in Great Britain are now linked to Blockbuster Weight loss Jabs, according to official data.
Two of the victims were people in the twenties, according to a MailOnline analysis of logs that were stored by the Medicine Safety Watchdog.
Of the 107 fatalities reported by doctors and patients, the vast majority of slimming Jabs that have been approved in recent years are, such as Mounjaro and Ozempic.
The findings come when the Medicines and Healthcare Products Regulatory Agency (MHRA) confirmed that at least 10 people in the UK had died of pancreatitis with the help of the injections; A life -threatening inflammation of the pancreas.
Civil servants announced last night that they are now investigating if the condition is more likely to meet some patients with specific genes.
It only comes a few months after the death of the 58-year-old Scottish nurse Susan McGowan who, after just two doses of Mounjaro-the so-called ‘King Kong’, suffered from weight loss Jabs.
Mrs. McGowan is currently the only fatality mentioned to the Jabs in the UK.
However, Medici have told about a Golf Young Women who need life-saving A & E treatment after obtaining the medicines Private from online pharmacies.
Susan McGowan, 58, from Lanarkshire, died of several organ failure last year, septic shock and pancreatitis after taking two low dose of Tirzepatide injections
In most of these cases, the victims had no weight -related health problems, but used the medicines for cosmetic reasons. Some were not even overweight.
Of the 107 dead taken by the MHRA, the majority were linked to a JAB with weight loss called Liraglutide, with 37 fatalities since 2010.
This medicine – sold under the Saxenda brand – works similar to the more famous brands Wegovy and Mounjaro and has been approved as a weight loss medicine in the UK.
The vast majority of fatalities in connection with the drug belonged to the more than 50s, although two were registered in patients in the twentys.
Semaglutide – the active ingredient in Ozempic and Wegovy – and Tirzepatide, sold as Mounjaro, had an equal number of coupled deadly victims with 30 each.
However, Mounjaro has achieved this totally much faster, with 30 reports that are associated with dead in just a year and a half.
Semaglutide took five and a half years to reach this number of linked fatalities.
Mounjaro is called the ‘King Kong’ of weight loss Jabs because of the potential, so that people in a year lose one fifth of their body weight.
Twelve other deaths were registered for comparable medicines-collective known as ‘GLP-1’ injections but that are only approved for use in the treatment of diabetes.
Injections of weight loss work by simulating natural appetite to suppress hormones to make people feel fuller and help them lose weight.
All deaths were recorded under the ‘Yellow Card’ schedule of the medicines and the Healthcare Products (MHRA).
The system-in the aftermath of the Thalidomide scandal of the 1960s is able to follow officials to follow potential side effects on medicines approved for use in the UK and emerging patterns.
Every medicine approved for us in the UK must go through safety tests before they are made available to the public.
But there is an inevitable risk that rare reactions or interactions with other diseases and disorders may have been missed, where the yellow card system enters.
If a worrying pattern comes forward, this can lead to the approval of drugs being assessed, thereby added new warnings to the labels or the medication that may be completely removed from the market.
As everyone can use the system – patient and their doctors – a death that is linked to a specific medicine is not proof that it was responsible.
The MHRA emphasizes that some reactions – including fatal – may be just a coincidence.
For example, a patient who takes a JAB can experience a fatal heart attack, but the event may have nothing to do with the medicine they used at that time.
Last night the MHRA said it had received more than 560 reports from patients who developed an inflamed pancreas by taking GLP-1 injections since they were first launched.
Although these drugs are often used for weight management, some such as Ozempic mainly have a permit for the treatment of type 2 diabetes.
Of the 10 linked fatalities of pancreatitis, five were connected to Mounjaro.
Scientists are not entirely clear why GLP-1 drugs can cause fatal pancreatitis.
Experts suspect, however, that the reaction is caused by how the drugs interact with the pancreas by activating it to release the hormone, so that the blood sugar level is stabilized.
Scientists say that in some cases this can ‘over -stimulate’ cells in the organ –Excess load on it – and ensure that the pancreas becomes seriously inflamed.
It is estimated that 1.5 million people in the UK use weight loss Jabs every month
The MHRA now calls for users who are admitted to the hospital with pancreatitis to report the side effect to authorities using the yellow card schedule of the regulator.
Health workers can also submit a report on behalf of patients.
Such patients will then be contacted by the MHRA to ask them to participate in a new study, to see if they have a gene that makes them a higher risk of pancreatitis while using the medicines.
The ultimate goal is to take a test with which doctors can discover whether a patient has this pancreatitis-risk-genes before they prescribe the medicines.
Patient safety magazines Divided with Ozempic, Wegovy, Mounjaro and Saxenda all recognize pancreatitis as a potential rare response to taking the medicine.
The most important symptom of pancreatitis is severe stomach pain that shines to the back and does not disappear.
Everyone who experiences this must seek immediate medical help.
Mrs. McGowan-De only deadly appointed by using Jabs of weight loss in the UK trick Mounjaro for a period of two weeks before her death on 4 September last year.
Both Wegovy and Mounjaro work by regulating the appetite of patients, making people feel full faster, but Mounjaro would have an extra effect because it seems to change the metabolism of the body
Only a few days after using the drug, she started to get severe stomach pain and went to A&E in the hospital where she worked, university hospital Monkands in Airdrie, Scotland.
Although her colleagues fought to save her, she died shortly thereafter.
Her deed of death stated several organ failure, septic shock and pancreatitis as the immediate death cause, but added the prescribed use of tirzepatide as a factor.
The announcement of the MHRA comes a day after experts have issued the GPs guidance to look for two life -threatening disorders that can be activated by weight loss Jabs Acute pancreatitis and gal disorders.
The advice tells doctors to look for signs of two life-threatening disorders that can be activated by the medication-acute pancreatitis and gall conditions.
Warnings for the possible side effects of taking weight loss jokes, just like the government, makes it easier for British to take them.
This week, patients in England can be able to be able to do Mounjaro for the first time this week, through their doctor.
The weekly injection will be offered to around 220,000 people in the next three years according to the new NHS prescription rules.
Under earlier regulations, patients could only gain access to Mounjaro on the NHS through a limited number of specialist clinics for weight loss that are carried out by the health service.
Recent estimates suggest that around 1.5 million people in the UK Jabs decrease, many of which are purchased privately because of NHS rationing.
Health officials have suggested that they can help to turn the tide on obesity, but have emphasized that they are not a silver bullet and have side effects.
Most side effects linked to the Jabs are gastrointestinal, including nausea, constipation and diarrhea.
However, the medical regulator has recently warned that Mounjaro can make the oral contraceptive pill less effective in some patients.
A spokesperson for Lilly UK, the makers of Mounjaro, who respond to reports of deaths related to the medicine, said that patient safety is the ‘top priority’.
They added: “Regular authorities perform extensive independent assessments of the benefits and risks of each new medicine and Lilly is dedicated to continuously monitor, evaluate and report safety data.”
“If someone experiences side effects when taking Lilly Medicine, they have to talk to his doctor or other care provider.”
In the US, almost 200 deaths are linked to Jabs for weight loss.
Just like the UK reporting system, it has been proven that none of the deaths were directly caused by the injections.
#Unveiled #shocking #number #deaths #linked #Jabs #weight #loss #health #leaders #give #horrifying #alert #side #effect #organ #destructive